Table 3 Multivariate analysis of stage IV patients with CRCLM (Cohort I).
From: Correlations between TBL1XR1 and recurrence of colorectal cancer
Variable | HR | 95% CI | P value |
|---|---|---|---|
CRCLM distribution | |||
Bilobar | 2.48 | 1.04~5.91 | 0.041* |
Unilobar | Reference | ||
Resection Margin | |||
R1 | 4.09 | 1.34~12.47 | 0.013* |
R0 | Reference | ||
Adjunctive chemotherapy | |||
No | 2.48 | 1.02~6.00 | 0.044* |
Yes | Reference | ||
TBL1XR1 expression in CRC | |||
High | 2.49 | 1.14~5.42 | 0.022* |
Low | Reference | ||
TBL1XR1 expression in CRCLM | |||
High | 2.07 | 0.85~5.04 | 0.110 |
Low | Reference | ||